Trial Profile
Efficacy of meningococcal vaccine group B OMV against gonorrhoea in young adults: A retrospective case-control study in New Zealand
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine group B OMV (Primary)
- Indications Meningococcal group B infections
- Focus Therapeutic Use
- 17 Jul 2017 New trial record